C2016-06 – Engineered Fibroblast Growth Factor for Enhanced Wound Healing

Technology # 16-06 A technology for Enhanced Wound Healing Fibroblast Growth Factor (FGF) is a naturally occurring substance in the body that has many roles. One of them is to help heal wounds, FGF causes the wound to grow new blood vessels and new nerves. Currently FGF is used commercially to help in the healing of wounds, however, the version of FGF now used for this purpose is quickly degraded by the presence near a wound of thrombin, which is a blood coagulant. A new type of engineered FGF has been invented that resists the degradation of thrombin, and has higher biological activity in the blood stream, thus leading to its being more effective in wound healing. The new version of FGF has been shown to have twice the wound healing property of natural FGF. The invention is available for licensing. For interested parties seeking further information, feel free to contact: Mark Allen Lanoue Technology Manager / Tech Ventures University of Arkansas (479) 575-7243 malanoue@uark.edu Technology Ventures ventures@uark.edu 479-575-7243

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More